Remepy Secures $36 Million Series A to Advance Hybrid Drug Platform and Parkinson’s Phase III Trial

August 12, 2026

More like this

August 12, 2026

Remepy Raises $36 Million Series A To Advance Hybridopa Phase III And Hybrid Drug Pipeline

Pulse 2.0

August 13, 2026

Remepy Raises $36M to Advance Hybrid Drugs Into Phase II

Tech Lens Media

August 12, 2026

Hybrid Drug Pioneer Remepy Secures $36 Million in Series A Funding

Startup Researcher